{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:40:18Z","timestamp":1790804418264,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10067-020-05549-8","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T04:17:40Z","timestamp":1610338660000},"page":"3039-3051","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"40","author":[{"given":"Xin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"issue":"10103","key":"5549_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685\u20131699. https:\/\/doi.org\/10.1016\/S0140-6736(17)30933-9","journal-title":"Lancet"},{"issue":"7","key":"5549_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","volume":"15","author":"M Cutolo","year":"2019","unstructured":"Cutolo M, Soldano S, Smith V (2019) Pathophysiology of systemic sclerosis: current understanding and new insights. Expert Rev Clin Immunol 15(7):753\u2013764. https:\/\/doi.org\/10.1080\/1744666X.2019.1614915","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"5549_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.berh.2018.08.005","volume":"32","author":"F Ingegnoli","year":"2018","unstructured":"Ingegnoli F, Ughi N, Mihai C (2018) Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis. Best Pract Res Clin Rheumatol 32(2):223\u2013240. https:\/\/doi.org\/10.1016\/j.berh.2018.08.005","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"5549_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.autrev.2016.01.007","volume":"15","author":"AC Desbois","year":"2016","unstructured":"Desbois AC, Cacoub P (2016) Systemic sclerosis: an update in 2016. Autoimmun Rev 15(5):417\u2013426. https:\/\/doi.org\/10.1016\/j.autrev.2016.01.007","journal-title":"Autoimmun Rev"},{"issue":"1","key":"5549_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4172\/2161-1149.1000235","volume":"8","author":"IM McFarlane","year":"2018","unstructured":"McFarlane IM, Bhamra MS, Kreps A et al (2018) Gastrointestinal manifestations of systemic sclerosis. Rheumatology (Sunnyvale) 8(1):235. https:\/\/doi.org\/10.4172\/2161-1149.1000235","journal-title":"Rheumatology (Sunnyvale)"},{"issue":"7","key":"5549_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/MCG.0000000000000334","volume":"49","author":"S Bharadwaj","year":"2015","unstructured":"Bharadwaj S, Tandon P, Gohel T, Corrigan ML, Coughlin KL, Shatnawei A, Chatterjee S, Kirby DF (2015) Gastrointestinal manifestations, malnutrition, and role of enteral and parenteral nutrition in patients with scleroderma. J Clin Gastroenterol 49(7):559\u2013564. https:\/\/doi.org\/10.1097\/MCG.0000000000000334","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"5549_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s10620-018-4977-8","volume":"63","author":"LI Sakkas","year":"2018","unstructured":"Sakkas LI, Simopoulou T, Daoussis D, Liossis SN, Potamianos S (2018) Intestinal involvement in systemic sclerosis: a clinical review. Dig Dis Sci 63(4):834\u2013844. https:\/\/doi.org\/10.1007\/s10620-018-4977-8","journal-title":"Dig Dis Sci"},{"issue":"1","key":"5549_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2017.09.002","volume":"44","author":"TM Frech","year":"2018","unstructured":"Frech TM, Mar D (2018) Gastrointestinal and hepatic disease in systemic sclerosis. Rheum Dis Clin N Am 44(1):15\u201328. https:\/\/doi.org\/10.1016\/j.rdc.2017.09.002","journal-title":"Rheum Dis Clin N Am"},{"issue":"24","key":"5549_CR9","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","volume":"16","author":"J Bures","year":"2010","unstructured":"Bures J, Cyrany J, Kohoutova D, F\u00f6rstl M, Rejchrt S, Kvetina J, Vorisek V, Kopacova M (2010) Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 16(24):2978\u20132990. https:\/\/doi.org\/10.3748\/wjg.v16.i24.2978","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"5549_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2036.2009.03951.x","volume":"29","author":"A Gasbarrini","year":"2009","unstructured":"Gasbarrini A, Corazza GR, Gasbarrini G et al (2009) Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference [published correction appears in Aliment Pharmacol Ther. 2010 Jan;31(1):166. Satta PU [corrected to Usai-Satta P]]. Aliment Pharmacol Ther 29(Suppl 1):1\u201349. https:\/\/doi.org\/10.1111\/j.1365-2036.2009.03951.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"5549_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-018-1874-0","volume":"311","author":"B Polkowska-Pruszy\u0144ska","year":"2019","unstructured":"Polkowska-Pruszy\u0144ska B, Gerkowicz A, Szczepanik-Ku\u0142ak P, Krasowska D (2019) Small intestinal bacterial overgrowth in systemic sclerosis: a review of the literature. Arch Dermatol Res 311(1):1\u20138. https:\/\/doi.org\/10.1007\/s00403-018-1874-0","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"5549_CR12","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/rheumatology\/key175","volume":"57","author":"N Pittman","year":"2018","unstructured":"Pittman N, Rawn SM, Wang M, Masetto A, Beattie KA, Larch\u00e9 M (2018) Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review. Rheumatology (Oxford) 57(10):1802\u20131811. https:\/\/doi.org\/10.1093\/rheumatology\/key175","journal-title":"Rheumatology (Oxford)"},{"key":"5549_CR13","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA. statement. PLoS Med 6:e1000097","journal-title":"PLoS Med"},{"key":"5549_CR14","unstructured":"Wells G (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses[C]. Symposium on Systematic Reviews: Beyond the Basics"},{"key":"5549_CR15","volume-title":"Development of a quality appraisal tool for case series studies using a modified Delphi technique","author":"C Moga","year":"2012","unstructured":"Moga C, Guo B et al (2012) Development of a quality appraisal tool for case series studies using a modified Delphi technique. Edmonton, Institute of Health Economics"},{"issue":"4","key":"5549_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1007\/s10620-019-05830-0","volume":"65","author":"G Garc\u00eda-Collinot","year":"2020","unstructured":"Garc\u00eda-Collinot G, Madrigal-Santill\u00e1n EO, Mart\u00ednez-Bencomo MA, Carranza-Muleiro RA, Jara LJ, Vera-Lastra O, Montes-Cortes DH, Medina G, Cruz-Dom\u00ednguez MP (2020) Effectiveness of Saccharomyces boulardii and metronidazole for small intestinal bacterial overgrowth in systemic sclerosis. Dig Dis Sci 65(4):1134\u20131143. https:\/\/doi.org\/10.1007\/s10620-019-05830-0","journal-title":"Dig Dis Sci"},{"issue":"4","key":"5549_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/1756-185X.13495","volume":"22","author":"K Sawadpanich","year":"2019","unstructured":"Sawadpanich K, Soison P, Chunlertrith K, Mairiang P, Sukeepaisarnjaroen W, Sangchan A, Suttichaimongkol T, Foocharoen C (2019) Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients. Int J Rheum Dis 22(4):695\u2013699. https:\/\/doi.org\/10.1111\/1756-185X.13495","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"5549_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2174\/1573397113666170425145405","volume":"14","author":"MB Adarsh","year":"2018","unstructured":"Adarsh MB, Sharma SK, Sinha SK, Bhattacharya A, Rana S, Dhir V, Singh S (2018) Gastrointestinal dysmotility and infections in systemic sclerosis- an Indian scenario. Curr Rheumatol Rev 14(2):172\u2013176. https:\/\/doi.org\/10.2174\/1573397113666170425145405","journal-title":"Curr Rheumatol Rev"},{"issue":"6","key":"5549_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.autrev.2015.01.018","volume":"14","author":"I Marie","year":"2015","unstructured":"Marie I, Leroi AM, Menard JF, Levesque H, Quillard M, Ducrotte P (2015) Fecal calprotectin in systemic sclerosis and review of the literature. Autoimmun Rev 14(6):547\u2013554. https:\/\/doi.org\/10.1016\/j.autrev.2015.01.018","journal-title":"Autoimmun Rev"},{"key":"5549_CR20","unstructured":"Tauber M, Avouac J, Benahmed A, Barbot L, Coustet B, Kahan A, Allanore Y (2014) Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms. Clin Exp Rheumatol 32(6 Suppl 86):S-82-7"},{"issue":"6","key":"5549_CR21","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/rheumatology\/kes429","volume":"52","author":"E Savarino","year":"2013","unstructured":"Savarino E, Mei F, Parodi A, Ghio M, Furnari M, Gentile A, Berdini M, di Sario A, Bendia E, Bonazzi P, Scarpellini E, Laterza L, Savarino V, Gasbarrini A (2013) Gastrointestinal motility disorder assessment in systemic sclerosis. Rheumatology (Oxford) 52(6):1095\u20131100. https:\/\/doi.org\/10.1093\/rheumatology\/kes429","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"5549_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.semarthrit.2012.09.004","volume":"42","author":"L Gemignani","year":"2013","unstructured":"Gemignani L, Savarino V, Ghio M, Parodi A, Zentilin P, de Bortoli N, Negrini S, Furnari M, Dulbecco P, Giambruno E, Savarino E (2013) Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. Semin Arthritis Rheum 42(5):522\u2013529. https:\/\/doi.org\/10.1016\/j.semarthrit.2012.09.004","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"5549_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3109\/00365521.2011.603158","volume":"46","author":"L Fynne","year":"2011","unstructured":"Fynne L, Wors\u00f8e J, Gregersen T, Schlageter V, Laurberg S, Krogh K (2011) Gastrointestinal transit in patients with systemic sclerosis. Scand J Gastroenterol 46(10):1187\u20131193. https:\/\/doi.org\/10.3109\/00365521.2011.603158","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"5549_CR24","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/rheumatology\/kep226","volume":"48","author":"I Marie","year":"2009","unstructured":"Marie I, Ducrott\u00e9 P, Denis P, Menard JF, Levesque H (2009) Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology (Oxford) 48(10):1314\u20131319. https:\/\/doi.org\/10.1093\/rheumatology\/kep226","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"5549_CR25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/j.1572-0241.2007.01758.x","volume":"103","author":"A Parodi","year":"2008","unstructured":"Parodi A, Sessarego M, Greco A, Bazzica M, Filaci G, Setti M, Savarino E, Indiveri F, Savarino V, Ghio M (2008) Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol 103(5):1257\u20131262. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01758.x","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"5549_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/rheumatology\/34.3.265","volume":"34","author":"SA Kaye","year":"1995","unstructured":"Kaye SA, Lim SG, Taylor M, Patel S, Gillespie S, Black CM (1995) Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol 34(3):265\u2013269. https:\/\/doi.org\/10.1093\/rheumatology\/34.3.265","journal-title":"Br J Rheumatol"},{"issue":"8","key":"5549_CR27","first-page":"495","volume":"87","author":"SA Kaye","year":"1994","unstructured":"Kaye SA, Seifalian AM, Lim SG, Hamilton G, Black CM (1994) Ischaemia of the small intestine in patients with systemic sclerosis: Raynaud\u2019s phenomenon or chronic vasculopathy? QJM 87(8):495\u2013500","journal-title":"QJM"},{"issue":"10","key":"5549_CR28","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/BF02090373","volume":"39","author":"M Wegener","year":"1994","unstructured":"Wegener M, Adamek RJ, Wedmann B, Jergas M, Altmeyer P (1994) Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 39(10):2209\u20132215. https:\/\/doi.org\/10.1007\/BF02090373","journal-title":"Dig Dis Sci"},{"issue":"1","key":"5549_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2230.1980.tb01662.x","volume":"5","author":"I Cobden","year":"1980","unstructured":"Cobden I, Axon AT, Ghoneim AT, McGoldrick J, Rowell NR (1980) Small intestinal bacterial growth in systemic sclerosis. Clin Exp Dermatol 5(1):37\u201342. https:\/\/doi.org\/10.1111\/j.1365-2230.1980.tb01662.x","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"5549_CR30","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Van den Hoogen","year":"2013","unstructured":"Van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"5549_CR31","doi-asserted-by":"publisher","unstructured":"(1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581\u2013590. https:\/\/doi.org\/10.1002\/art.1780230510","DOI":"10.1002\/art.1780230510"},{"issue":"7","key":"5549_CR32","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28(7):1573\u20131576","journal-title":"J Rheumatol"},{"issue":"2","key":"5549_CR33","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202\u2013205","journal-title":"J Rheumatol"},{"issue":"9","key":"5549_CR34","first-page":"1855","volume":"34","author":"SR Johnson","year":"2007","unstructured":"Johnson SR, Feldman BM, Hawker GA (2007) Classification criteria for systemic sclerosis subsets. J Rheumatol 34(9):1855\u20131863","journal-title":"J Rheumatol"},{"issue":"12","key":"5549_CR35","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/art.1780241226","volume":"24","author":"PL Tan","year":"1981","unstructured":"Tan PL, Wigley RD, Borman GB (1981) Clinical criteria for systemic sclerosis. Arthritis Rheum 24(12):1589\u20131590. https:\/\/doi.org\/10.1002\/art.1780241226","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5549_CR36","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F","volume":"44","author":"LS Lonzetti","year":"2001","unstructured":"Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, Choquette D, Raymond Y, Sen\u00e9cal JL (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44(3):735\u2013736. https:\/\/doi.org\/10.1002\/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F","journal-title":"Arthritis Rheum"},{"issue":"5","key":"5549_CR37","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1053\/berh.2002.0258","volume":"16","author":"G Valentini","year":"2002","unstructured":"Valentini G, Black C (2002) Systemic sclerosis. Best Pract Res Clin Rheumatol 16(5):807\u2013816. https:\/\/doi.org\/10.1053\/berh.2002.0258","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5549_CR38","unstructured":"Sorathia SJ, Rivas JM (2020) Small intestinal bacterial overgrowth. In: StatPearls. StatPearls Publishing, Treasure Island"},{"issue":"5","key":"5549_CR39","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10620-007-0018-8","volume":"53","author":"R Domsic","year":"2008","unstructured":"Domsic R, Fasanella K, Bielefeldt K (2008) Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci 53(5):1163\u20131174. https:\/\/doi.org\/10.1007\/s10620-007-0018-8","journal-title":"Dig Dis Sci"},{"issue":"1","key":"5549_CR40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.advms.2014.09.001","volume":"60","author":"A Miazga","year":"2015","unstructured":"Miazga A, Osi\u0144ski M, Cichy W, \u017baba R (2015) Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO. Adv Med Sci 60(1):118\u2013124. https:\/\/doi.org\/10.1016\/j.advms.2014.09.001","journal-title":"Adv Med Sci"},{"issue":"6","key":"5549_CR41","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/0002-9343(79)90647-8","volume":"67","author":"PE Isaacs","year":"1979","unstructured":"Isaacs PE, Kim YS (1979) The contaminated small bowel syndrome. Am J Med 67(6):1049\u20131057. https:\/\/doi.org\/10.1016\/0002-9343(79)90647-8","journal-title":"Am J Med"},{"issue":"3","key":"5549_CR42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/MOG.0000000000000348","volume":"33","author":"I Aziz","year":"2017","unstructured":"Aziz I, T\u00f6rnblom H, Simr\u00e9n M (2017) Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty? Curr Opin Gastroenterol 33(3):196\u2013202. https:\/\/doi.org\/10.1097\/MOG.0000000000000348","journal-title":"Curr Opin Gastroenterol"},{"issue":"2","key":"5549_CR43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5009\/gnl16126","volume":"11","author":"UC Ghoshal","year":"2017","unstructured":"Ghoshal UC, Shukla R, Ghoshal U (2017) small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy. Gut Liver 11(2):196\u2013208. https:\/\/doi.org\/10.5009\/gnl16126","journal-title":"Gut Liver"},{"key":"5549_CR44","doi-asserted-by":"publisher","first-page":"7424831","DOI":"10.1155\/2016\/7424831","volume":"2016","author":"A Therrien","year":"2016","unstructured":"Therrien A, Bouchard S, Sidani S, Bouin M (2016) Prevalence of small intestinal bacterial overgrowth among chronic pancreatitis patients: a case-control study. Can J Gastroenterol Hepatol 2016:7424831\u20137424837. https:\/\/doi.org\/10.1155\/2016\/7424831","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"3","key":"5549_CR45","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/gut.2009.205476","volume":"60","author":"D Yu","year":"2011","unstructured":"Yu D, Cheeseman F, Vanner S (2011) Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut 60(3):334\u2013340. https:\/\/doi.org\/10.1136\/gut.2009.205476","journal-title":"Gut"},{"issue":"3","key":"5549_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5056\/jnm.2011.17.3.312","volume":"17","author":"UC Ghoshal","year":"2011","unstructured":"Ghoshal UC (2011) How to interpret hydrogen breath tests. J Neurogastroenterol Motil 17(3):312\u2013317. https:\/\/doi.org\/10.5056\/jnm.2011.17.3.312","journal-title":"J Neurogastroenterol Motil"},{"issue":"12","key":"5549_CR47","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.cgh.2013.09.055","volume":"12","author":"RJ Saad","year":"2014","unstructured":"Saad RJ, Chey WD (2014) Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy. Clin Gastroenterol Hepatol 12(12):1964\u2013e120. https:\/\/doi.org\/10.1016\/j.cgh.2013.09.055","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"5549_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12967-017-1175-y","volume":"15","author":"RK Singh","year":"2017","unstructured":"Singh RK, Chang HW, Yan D et al (2017) Influence of diet on the gut microbiome and implications for human health. J Transl Med 15(1):73. Published 2017 Apr 8. https:\/\/doi.org\/10.1186\/s12967-017-1175-y","journal-title":"J Transl Med"},{"issue":"8","key":"5549_CR49","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/apt.12479","volume":"38","author":"SC Shah","year":"2013","unstructured":"Shah SC, Day LW, Somsouk M, Sewell JL (2013) Meta-analysis: antibiotic therapy for small intestinal bacterial. overgrowth. Aliment Pharmacol Ther 38(8):925\u2013934. https:\/\/doi.org\/10.1111\/apt.12479","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"5549_CR50","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar J, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, M\u00fcller-Ladner U, EUSTAR Coauthors (2017) Update of EULAR recommendations for the treatment of systemic. sclerosis. Ann Rheum Dis 76(8):1327\u20131339. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209909","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05549-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05549-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05549-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T10:10:58Z","timestamp":1626689458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05549-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["5549"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05549-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"26 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}